Literature DB >> 18389333

Abdominal obesity and inflammation predicts hypertension among prehypertensive men and women: the ATTICA Study.

Christos Pitsavos1, Christina Chrysohoou, Demosthenes B Panagiotakos, Yannis Lentzas, Christodoulos Stefanadis.   

Abstract

The aim of this work was to assess the 5-year incidence of hypertension and its predictors among prehypertensive adults. Under the context of the ATTICA Study, data from 1188 individuals, free of cardiovascular disease, but with defined high blood pressure levels (prehypertension) at baseline examination (during 2001-2002) were retrieved. In 2006, the 5-year follow-up of the study was performed, and 798 of the prehypertensive participants were allocated. In this work, incidence and determinants of developing hypertension were evaluated. The 5-year ageadjusted incidence of hypertension was 18.7% in men and 24.6% in women (P = 0.05); while almost one half of prehypertensive individuals at the age of 55-65 years developed hypertension, and approximately 6 out of 10 people over 65 years of age developed the disease. Multiple logistic regression analysis revealed that increased age (odds ratio [OR] per 1 year = 1.09, 95% confidence interval [CI] 1.07-1.12), male sex (OR = 0.40, 95% CI 0.21-0.68), high education status (OR per 1 year of school = 0.94, 95% CI 0.88-0.98), waist circumference (OR per 1 cm = 1.04, 95% CI 1.02-1.06) and C-reactive protein (OR per 1 mg/l = 1.12, 95% CI 1.05-1.20), were positively associated with the development of hypertension. Moreover, greater adherence to Mediterranean diet seems to protect only prehypertensive, with abdominal obesity patients prone to develop hypertension (OR = 0.94, 95% CI 0.90-0.98). Annual incidence of hypertension was roughly 4% in men and women. Older people, with low education, abdominal obesity, lower adherence to the Mediterranean diet, and increased inflammation, constitute a model of prehypertensive individuals that are prone to develop hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18389333     DOI: 10.1007/s00380-007-1018-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  37 in total

1.  Education as an important risk factor for the prevalence of hypertension and elevated blood pressure in Chinese men and women.

Authors:  Y Wang; J Chen; K Wang; C L Edwards
Journal:  J Hum Hypertens       Date:  2006-09-14       Impact factor: 3.012

2.  Incidence and correlates of hypertension in the Atherosclerosis Risk in Communities (ARIC) study and the Monitoring Trends and Determinants of Cardiovascular Disease (POL-MONICA) project.

Authors:  S L Rywik; O D Williams; A Pajak; G Broda; C E Davis; E Kawalec; T A Manolio; W Piotrowski; R Hutchinson
Journal:  J Hypertens       Date:  2000-08       Impact factor: 4.844

3.  The relation of body fat mass and distribution to markers of chronic inflammation.

Authors:  A Festa; R D'Agostino; K Williams; A J Karter; E J Mayer-Davis; R P Tracy; S M Haffner
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

4.  Increased levels of transforming growth factor-beta1 in essential hypertension.

Authors:  Ulla Derhaschnig; Medhat Shehata; Harald Herkner; Andreas Bur; Christian Woisetschläger; Anton N Laggner; Michael M Hirschl
Journal:  Am J Hypertens       Date:  2002-03       Impact factor: 2.689

5.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

6.  Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures.

Authors:  Giuseppe Schillaci; Matteo Pirro; Fabio Gemelli; Leonella Pasqualini; Gaetano Vaudo; Simona Marchesi; Donatella Siepi; Francesco Bagaglia; Elmo Mannarino
Journal:  J Hypertens       Date:  2003-10       Impact factor: 4.844

7.  Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the Attica study.

Authors:  Demosthenes B Panagiotakos; Christos H Pitsavos; Christina Chrysohoou; John Skoumas; Lambros Papadimitriou; Christodoulos Stefanadis; Pavlos K Toutouzas
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

8.  Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.

Authors:  Christina Chrysohoou; Demosthenes B Panagiotakos; Christos Pitsavos; Undurti N Das; Christodoulos Stefanadis
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

9.  The diet and 15-year death rate in the seven countries study.

Authors:  A Keys; A Menotti; M J Karvonen; C Aravanis; H Blackburn; R Buzina; B S Djordjevic; A S Dontas; F Fidanza; M H Keys
Journal:  Am J Epidemiol       Date:  1986-12       Impact factor: 4.897

Review 10.  The impact of health literacy on cardiovascular disease.

Authors:  Richard S Safeer; Catherine E Cooke; Jann Keenan
Journal:  Vasc Health Risk Manag       Date:  2006
View more
  21 in total

Review 1.  Prehypertension: a meta-analysis of the epidemiology, risk factors, and predictors of progression.

Authors:  Xiaofan Guo; Liling Zou; Xingang Zhang; Jue Li; Liqiang Zheng; Zhaoqing Sun; Jian Hu; Nathan D Wong; Yingxian Sun
Journal:  Tex Heart Inst J       Date:  2011

2.  Higher serum uric acid level increases risk of prehypertension in subjects with normal glucose tolerance, but not pre-diabetes and diabetes.

Authors:  I-H Wu; J-S Wu; Z-J Sun; F-H Lu; C-S Chang; C-J Chang; Y-C Yang
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

3.  Multilevel analysis of the determinants of pre-hypertension and hypertension in rural southwest China.

Authors:  Cai Le; Dong Jun; Lu Yichun; Shu Zhankun; Zhao Keying
Journal:  Public Health Rep       Date:  2011 May-Jun       Impact factor: 2.792

4.  Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients.

Authors:  Chiung-Mei Weng; Chang-Hua Chou; Yao-Yi Huang; Chih-Chan Lin; Yen-Wen Liu; Wei-Chuan Tsai
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

5.  Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome.

Authors:  Kunihisa Miwa; Masatoshi Fujita
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 6.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

7.  The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study.

Authors:  Mizue Fujii; Hirofumi Ohnishi; Shigeyuki Saitoh; Hiroshi Akasaka; Tetsuji Miura; Mitsuru Mori
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

8.  Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.

Authors:  Jing Chen; Joshua D Bundy; L Lee Hamm; Chi-Yuan Hsu; James Lash; Edgar R Miller; George Thomas; Debbie L Cohen; Matthew R Weir; Dominic S Raj; Hsiang-Yu Chen; Dawei Xie; Panduranga Rao; Jackson T Wright; Mahboob Rahman; Jiang He
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

9.  Validity of self-reported height, weight, and body mass index: findings from the National Health and Nutrition Examination Survey, 2001-2006.

Authors:  Ray M Merrill; John S Richardson
Journal:  Prev Chronic Dis       Date:  2009-09-15       Impact factor: 2.830

10.  Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems.

Authors:  Evros K Vassiliou; Andres Gonzalez; Carlos Garcia; James H Tadros; Goutam Chakraborty; Jeffrey H Toney
Journal:  Lipids Health Dis       Date:  2009-06-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.